The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
Name | % Net Assets |
---|---|
Merck & Co | 2.7% |
Goldman Sachs | 2.7% |
Morgan Stanley | 2.7% |
Chevron | 2.6% |
Comcast | 2.6% |
Wells Fargo | 2.6% |
Pfizer | 2.6% |
Morgan Stanley | 2.6% |
Occidental Petroleum | 2.6% |
Hewlett Packard | 2.5% |
Key | % Net Assets |
---|---|
Merck & Co | 2.7% |
Goldman Sachs | 2.7% |
Morgan Stanley | 2.7% |
Chevron | 2.6% |
Other | 89.3% |
Date | 09-Nov-2018 |
---|---|
NAV | 24.79 |
Currency | EUR |
Change | 0.52 |
% | 2.16% |
YTD change | 24.79 |
YTD % | n/a |
Fund Inception | 01/07/2005 |
---|---|
Fund Manager | Richard Brody |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.05 |
You are here: research